Printer Friendly

CEO of Imaging Diagnostic Systems Goes on Bloomberg Forum to Explain Ultra-Fast Laser Imaging Technology to Investors

FT. LAUDERDALE, Fla., Nov. 22 /PRNewswire/ -- Imaging Diagnostic Systems Inc., (IDS) traded on the (OTC) Bulletin Board under the symbol (IMDS) said today that its CEO, Richard Grable will be interviewed on Bloomberg Forum at 11 a.m. on Monday, November 25th in New York City.

"We're thrilled to have the opportunity to communicate directly to the investment community the importance of the technology that we're developing and the impact that it may have on the mammography industry once we receive our FDA approval," said Deborah O'Brien, IDS's Director of Investor Relations.

According to Ms. O'Brien, Bloomberg's format for interviews usually combine a look at long-term strategy with current news. A news article based on the on-camera interview will appear on the Bloomberg terminal reaching over 250,000 investment professionals worldwide. The article will also run on the Bloomberg newswires, which reach 162 major newspapers worldwide.

In other developments the company reported that it has filed two provisional patent applications. On going research and development efforts have resulted in patentable technological advances in the medical optical imaging field.

Grable said, "Both of the applications involve direct solutions to portions of the image reconstruction process. One development reduces the time required to reconstruct an image by about one third." Grable believes this patent may prove to be pivotal to all image reconstruction methods in optical imaging.

Grable continued, "The second patent application deals with a data acquisition problem. The method allows almost total elimination of reflected light that impedes data acquisition."

"The time has come for the CTLM to take its rightful place amongst other imaging technologies," said Richard Grable. Just weeks away from the RSNA conference, "I think that the industry will be taking IDS and its CT Laser Mammography a little more seriously as a major competitor in the market place after this year's RSNA conference in Chicago," Grable added.

The CTLM(TM) is a revolutionary device that uses an innovative laser technology to produce three dimensional cross-sectional images of the breast. It's currently being tested under the provision of the IDE program as a possible diagnostic tool which could mean a practical, painless, and radiation-free alternative to traditional mammography.

SOURCE Imaging Diagnostic Systems Inc.
 -0- 11/22/96


/CONTACT: Deborah O'Brien, Investor Relations, of Imaging Diagnostic Systems Inc., 954-746-0500; Margie Adelman, Media, of TransMedia Consultants, 561-998-4888/

(IMDS)

CO: Imaging Diagnostic Systems Inc. ST: Florida IN: CPR MTC SU:

WW-GW -- NYF007 -- 5657 11/22/96 08:00 EST http://www.prnewswire.com
COPYRIGHT 1996 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 22, 1996
Words:413
Previous Article:SQA Suite Voted Best Automated Client/Server Test Tool for 1996.
Next Article:Interim Knows No Reason for Recent Stock Activity Margins Remain Stable and Unchanged
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters